Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | LEO1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Leo1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of LEO1 mRNA | CTD | PMID:21570461 | LEO1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Leo1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of LEO1 mRNA | CTD | PMID:33387578 | LEO1 | Human | 2,4-dinitrotoluene | affects expression | ISO | Leo1 (Rattus norvegicus) | 6480464 | 2 and 4-dinitrotoluene affects the expression of LEO1 mRNA | CTD | PMID:21346803 | LEO1 | Human | 2,6-dinitrotoluene | affects expression | ISO | Leo1 (Rattus norvegicus) | 6480464 | 2 and 6-dinitrotoluene affects the expression of LEO1 mRNA | CTD | PMID:21346803 | LEO1 | Human | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Leo1 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of LEO1 mRNA | CTD | PMID:26251327 | LEO1 | Human | 3-chloropropane-1,2-diol | increases expression | ISO | Leo1 (Rattus norvegicus) | 6480464 | alpha-Chlorohydrin results in increased expression of LEO1 protein | CTD | PMID:34915118 | LEO1 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of LEO1 gene | CTD | PMID:27153756 | LEO1 | Human | all-trans-retinoic acid | increases expression | ISO | Leo1 (Rattus norvegicus) | 6480464 | Tretinoin results in increased expression of LEO1 mRNA | CTD | PMID:20488242 | LEO1 | Human | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of LEO1 mRNA | CTD | PMID:33167477 | LEO1 | Human | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of LEO1 mRNA | CTD | PMID:33212167 | LEO1 | Human | benzo[a]pyrene | increases expression | ISO | Leo1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of LEO1 mRNA | CTD | PMID:22228805 | LEO1 | Human | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:19150397 | LEO1 | Human | benzo[b]fluoranthene | decreases expression | ISO | Leo1 (Mus musculus) | 6480464 | benzo(b)fluoranthene results in decreased expression of LEO1 mRNA | CTD | PMID:26377693 | LEO1 | Human | bisphenol A | increases expression | ISO | Leo1 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of LEO1 mRNA | CTD | PMID:25181051 | LEO1 | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of LEO1 protein | CTD | PMID:33376534 | LEO1 | Human | caffeine | decreases phosphorylation | EXP | | 6480464 | Caffeine results in decreased phosphorylation of LEO1 protein | CTD | PMID:35688186 | LEO1 | Human | carbon nanotube | increases expression | ISO | Leo1 (Mus musculus) | 6480464 | Nanotubes and Carbon results in increased expression of LEO1 mRNA | CTD | PMID:25554681 and PMID:25620056 | LEO1 | Human | chloroprene | decreases expression | ISO | Leo1 (Rattus norvegicus) | 6480464 | Chloroprene results in decreased expression of LEO1 mRNA | CTD | PMID:23125180 | LEO1 | Human | chlorpyrifos | decreases expression | ISO | Leo1 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of LEO1 mRNA | CTD | PMID:37019170 | LEO1 | Human | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of LEO1 mRNA | CTD | PMID:19549813 | LEO1 | Human | coumarin | decreases phosphorylation | EXP | | 6480464 | coumarin results in decreased phosphorylation of LEO1 protein | CTD | PMID:35688186 | LEO1 | Human | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of LEO1 mRNA | CTD | PMID:20106945 | LEO1 | Human | Dibutyl phosphate | affects expression | EXP | | 6480464 | di-n-butylphosphoric acid affects the expression of LEO1 mRNA | CTD | PMID:37042841 | LEO1 | Human | dibutyl phthalate | decreases expression | ISO | Leo1 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of LEO1 mRNA | CTD | PMID:21266533 | LEO1 | Human | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of LEO1 mRNA | CTD | PMID:28302478 | LEO1 | Human | doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of LEO1 mRNA | CTD | PMID:29803840 | LEO1 | Human | FR900359 | increases phosphorylation | EXP | | 6480464 | FR900359 results in increased phosphorylation of LEO1 protein | CTD | PMID:37730182 | LEO1 | Human | hexadecanoic acid | increases phosphorylation | EXP | | 6480464 | Palmitic Acid results in increased phosphorylation of LEO1 protein | CTD | PMID:28073184 | LEO1 | Human | hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of LEO1 mRNA | CTD | PMID:20044591 | LEO1 | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of LEO1 protein | CTD | PMID:32959892 | LEO1 | Human | menadione | affects expression | EXP | | 6480464 | Vitamin K 3 affects the expression of LEO1 mRNA | CTD | PMID:20044591 | LEO1 | Human | methyl methanesulfonate | decreases expression | EXP | | 6480464 | Methyl Methanesulfonate results in decreased expression of LEO1 mRNA | CTD | PMID:23649840 | LEO1 | Human | nickel atom | increases expression | EXP | | 6480464 | Nickel results in increased expression of LEO1 mRNA | CTD | PMID:25583101 | LEO1 | Human | oxaliplatin | multiple interactions | ISO | Leo1 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of LEO1 mRNA | CTD | PMID:25729387 | LEO1 | Human | p-toluidine | decreases expression | ISO | Leo1 (Rattus norvegicus) | 6480464 | 4-toluidine results in decreased expression of LEO1 mRNA | CTD | PMID:27638505 | LEO1 | Human | paracetamol | decreases expression | ISO | Leo1 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of LEO1 mRNA | CTD | PMID:33387578 | LEO1 | Human | pirinixic acid | multiple interactions | ISO | Leo1 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of LEO1 mRNA | CTD | PMID:19710929 | LEO1 | Human | potassium dichromate | increases expression | EXP | | 6480464 | Potassium Dichromate results in increased expression of LEO1 protein | CTD | PMID:23718831 | LEO1 | Human | potassium dichromate | decreases expression | ISO | Leo1 (Mus musculus) | 6480464 | Potassium Dichromate results in decreased expression of LEO1 mRNA | CTD | PMID:23608068 | LEO1 | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of LEO1 mRNA | CTD | PMID:23557933 | LEO1 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of LEO1 protein | CTD | PMID:37664457 | LEO1 | Human | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide results in decreased expression of LEO1 mRNA | CTD | PMID:34973136 | LEO1 | Human | tetraphene | decreases expression | ISO | Leo1 (Mus musculus) | 6480464 | benz(a)anthracene results in decreased expression of LEO1 mRNA | CTD | PMID:26377693 | LEO1 | Human | thapsigargin | decreases expression | EXP | | 6480464 | Thapsigargin results in decreased expression of LEO1 mRNA | CTD | PMID:22378314 | LEO1 | Human | thioacetamide | increases expression | ISO | Leo1 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of LEO1 mRNA | CTD | PMID:34492290 | LEO1 | Human | titanium dioxide | increases expression | ISO | Leo1 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of LEO1 mRNA | CTD | PMID:23557971 | LEO1 | Human | titanium dioxide | increases methylation | EXP | | 6480464 | titanium dioxide results in increased methylation of LEO1 gene | CTD | PMID:34973136 | LEO1 | Human | titanium dioxide | increases methylation | ISO | Leo1 (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of LEO1 gene | CTD | PMID:35295148 | LEO1 | Human | titanium dioxide | decreases methylation | ISO | Leo1 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of LEO1 promoter | CTD | PMID:35295148 | LEO1 | Human | titanium dioxide | decreases expression | ISO | Leo1 (Rattus norvegicus) | 6480464 | titanium dioxide results in decreased expression of LEO1 mRNA | CTD | PMID:30012374 | LEO1 | Human | titanium dioxide | decreases expression | ISO | Leo1 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of LEO1 mRNA | CTD | PMID:29264374 | LEO1 | Human | topotecan | multiple interactions | ISO | Leo1 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of LEO1 mRNA | CTD | PMID:25729387 | LEO1 | Human | trichloroethene | decreases expression | ISO | Leo1 (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of LEO1 mRNA | CTD | PMID:33387578 | LEO1 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of LEO1 mRNA | CTD | PMID:37042841 | LEO1 | Human | tungsten | decreases expression | ISO | Leo1 (Mus musculus) | 6480464 | Tungsten results in decreased expression of LEO1 mRNA | CTD | PMID:30912803 | LEO1 | Human | tunicamycin | decreases expression | EXP | | 6480464 | Tunicamycin results in decreased expression of LEO1 mRNA | CTD | PMID:22378314 | LEO1 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of LEO1 mRNA | CTD | PMID:25979313 | |